PHLT (Performant Healthcare) EBITDA Margin %: 11.46% (As of Jun. 2025) — 533% Above Median


PHLT Performant Healthcare Inc PHLT
9 GF Score
Price $7.75
GF Value $3.24
! 4 Warning Signs
View Full Analysis

What is Performant Healthcare EBITDA Margin %?

Performant Healthcare PHLT 9 EBITDA Margin % is 11.46% as of Jun. 2025, which is 533% above its 10-year median of 1.81. GuruFocus rates PHLT with a GF Score™ of 9/100 and a GF Value™ of $3.24. The stock has 4 warning signs investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Performant Healthcare's EBITDA for the three months ended in Jun. 2025 was $4.3 Mil. Performant Healthcare's Revenue for the three months ended in Jun. 2025 was $37.8 Mil. Therefore, Performant Healthcare's EBITDA margin for the quarter that ended in Jun. 2025 was 11.46%.


Performant Healthcare  (NAS:PHLT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Performant Healthcare EBITDA Margin % Related Terms


Performant Healthcare EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Performant Healthcare's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Performant Healthcare EBITDA Margin % Chart

Performant Healthcare Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.45 6.50 0.28 0.73 -1.80

Performant Healthcare Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.20 -0.13 2.26 5.55 11.46

PHLT vs WEAV, HSTM, TALK: EBITDA Margin % Comparison

For the Health Information Services subindustry, Performant Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Performant Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Performant Healthcare's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Performant Healthcare's EBITDA Margin % falls into.


PHLT
9GF Score
Performant Healthcare Inc PHLT
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Performant Healthcare EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Performant Healthcare's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-2.21/122.981
=-1.80 %

Performant Healthcare's EBITDA Margin % for the quarter that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=4.331/37.803
=11.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 11.46% mean?
Performant Healthcare (PHLT) has a EBITDA Margin % of 11.46% as of Jun. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Performant Healthcare and its competitors. This is 533% above median its historical median of 1.81.
Is Performant Healthcare's EBITDA Margin % too high?
Performant Healthcare's current EBITDA Margin % of 11.46% is 533% above median its 10-year median of 1.81. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Performant Healthcare's value of 11.46% is 12.2% above this industry median. Overall, Performant Healthcare has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Performant Healthcare's EBITDA Margin % compare to WEAV and HSTM?
Performant Healthcare's EBITDA Margin % of 11.46% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. Performant Healthcare's value of 11.46% is 12.2% above this benchmark. While the company's 10-year median is 1.81 vs. the industry median of 10.21, Performant Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Performant Healthcare's current EBITDA Margin % of 11.46% is 12.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Performant Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Performant Healthcare's current EBITDA Margin % is 11.46%, which is 533% above median its own 10-year median of 1.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Performant Healthcare stock overvalued right now?
Performant Healthcare (PHLT) has a current EBITDA Margin % of 11.46%. The stock's GF Value™ is $3.24, compared to a current price of $7.75 — trading 139.2% above its estimated fair value. The current EBITDA Margin % is 11.46%, which is 533% above median its 10-year median of 1.81 and 12.2% above the Healthcare Providers & Services industry median of 10.21. Performant Healthcare's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Performant Healthcare (PHLT), the current EBITDA Margin % is 11.46% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Performant Healthcare (PHLT) Overvalued in 2026?

Based on GuruFocus' analysis, Performant Healthcare stock appears to be overvalued. The current stock price of $7.75 is trading 139.2% above its estimated GF Value™ of $3.24.

Key valuation signals for PHLT:

  • EBITDA Margin %: 11.46% (533% above median its 10-year median of 1.81)
  • GF Value™: $3.24 vs. price of $7.75 (139.2% above fair value)
  • GF Score™: 9/100 with 4 warning signs
  • Industry Position: 12.2% above the Healthcare Providers & Services median

No single metric tells the full story. See the PHLT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Performant Healthcare Business Description

Address 900 South Pine Island Road, Suite 150, Plantation, FL, USA, 33324
Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.
9GF Score

Get the complete analysis for PHLT

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.75
Price
$3.24
GF Value